The Effect of Thyrotropin Suppression on Survival Outcomes in Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

The Effect of Thyrotropin Suppression on Survival Outcomes in Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis

Published:2024-06-01 Issue:6 Volume:34 Page:674-686
ISSN:1050-7256
Container-title:Thyroid®
language:en
Short-container-title:Thyroid®

Author:

Gubbi Sriram¹^ORCID,Al-Jundi Mohammad¹,Foerster Peter¹,Cardenas Stephanie¹,Butera Gisela²,Auh Sungyoung¹,Wright Elizabeth Chalmers¹,Klubo-Gwiezdzinska Joanna¹

Affiliation:

1. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.

2. Division of Library Services, National Institutes of Health, Bethesda, Maryland, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2023.0711

Reference41 articles.

1. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

2. Benefits of Thyrotropin Suppression Versus the Risks of Adverse Effects in Differentiated Thyroid Cancer

3. Thyrotropin Suppression and Disease Progression in Patients with Differentiated Thyroid Cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry

4. Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy

5. Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global burden of thyroid cancer from 1990 to 2021: a systematic analysis from the Global Burden of Disease Study 2021;Journal of Hematology & Oncology;2024-08-27

2. Association of Free Thyroxine With Progression-Free Survival in Intermediate and High-Risk Differentiated Thyroid Cancer;The Journal of Clinical Endocrinology & Metabolism;2024-08-08

3. Recombinant Human TSH Fails to Induce the Proliferation and Migration of Papillary Thyroid Carcinoma Cell Lines;Cancers;2024-07-21

4. TSH Suppression in Differentiated Thyroid Cancer Patients. Still More Questions than Answers after 30 Years;Thyroid®;2024-06-01

5. Recombinant Human TSH Fails to Induce the Proliferation and Migration of Papillary Thyroid Carcinoma Cell Lines;2024-04-03